X4 Pharmaceuticals Management
Management criteria checks 4/4
X4 Pharmaceuticals' CEO is Paula Ragan, appointed in Jul 2014, has a tenure of 9.83 years. total yearly compensation is $2.04M, comprised of 30.3% salary and 69.7% bonuses, including company stock and options. directly owns 0.46% of the company’s shares, worth $879.84K. The average tenure of the management team and the board of directors is 3.1 years and 5.2 years respectively.
Key information
Paula Ragan
Chief executive officer
US$2.0m
Total compensation
| CEO salary percentage | 30.3% |
| CEO tenure | 9.8yrs |
| CEO ownership | 0.5% |
| Management average tenure | 3.1yrs |
| Board average tenure | 5.2yrs |
Recent management updates
Recent updates
Is X4 Pharmaceuticals (NASDAQ:XFOR) Weighed On By Its Debt Load?
Mar 26
Is X4 Pharmaceuticals (NASDAQ:XFOR) A Risky Investment?
Apr 19Is X4 Pharmaceuticals (NASDAQ:XFOR) Using Too Much Debt?
Oct 07X4 Pharmaceuticals: Upcoming Catalysts
Sep 19X4 Pharma to focus resources on lead drug candidate, cut workforce by about 20%
Jul 20X4 Pharmaceuticals to raise $55M in stock and warrants offering, debt facility amended
Jul 01X4 Pharma: Late Stage Nanocap Targeting Rare Diseases
Aug 03Is X4 Pharmaceuticals (NASDAQ:XFOR) Using Debt Sensibly?
Jun 22X4 Pharmaceuticals EPS misses by $0.44
May 06How Many X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Shares Do Institutions Own?
Mar 16X4 Pharmaceuticals EPS misses by $0.12
Nov 05CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$2m | US$620k | -US$101m |
| Sep 30 2023 | n/a | n/a | -US$111m |
| Jun 30 2023 | n/a | n/a | -US$131m |
| Mar 31 2023 | n/a | n/a | -US$96m |
| Dec 31 2022 | US$4m | US$583k | -US$96m |
| Sep 30 2022 | n/a | n/a | -US$103m |
| Jun 30 2022 | n/a | n/a | -US$102m |
| Mar 31 2022 | n/a | n/a | -US$100m |
| Dec 31 2021 | US$2m | US$562k | -US$103m |
| Sep 30 2021 | n/a | n/a | -US$85m |
| Jun 30 2021 | n/a | n/a | -US$82m |
| Mar 31 2021 | n/a | n/a | -US$78m |
| Dec 31 2020 | US$3m | US$543k | -US$62m |
| Sep 30 2020 | n/a | n/a | -US$55m |
| Jun 30 2020 | n/a | n/a | -US$55m |
| Mar 31 2020 | n/a | n/a | -US$53m |
| Dec 31 2019 | US$2m | US$492k | -US$53m |
| Sep 30 2019 | n/a | n/a | -US$55m |
| Jun 30 2019 | n/a | n/a | -US$46m |
| Mar 31 2019 | n/a | n/a | -US$40m |
| Dec 31 2018 | US$921k | US$380k | -US$36m |
Compensation vs Market: Paula's total compensation ($USD2.04M) is about average for companies of similar size in the US market ($USD1.63M).
Compensation vs Earnings: Paula's compensation has been consistent with company performance over the past year.
CEO
Paula Ragan (53 yo)
9.8yrs
Tenure
US$2,044,761
Compensation
Dr. Paula Ragan, Ph D., serves as Director of CAMP4 Therapeutics Corporation since October 2019. She is a Founder of X4 Pharmaceuticals Inc. and serves as its Chief Executive Officer, President and Directo...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 9.8yrs | US$2.04m | 0.46% $ 879.8k | |
| CFO, Treasurer & Corporate Secretary | 5.7yrs | US$1.15m | 0% $ 0 | |
| Chief Operating Officer | 2.7yrs | US$1.84m | 0.17% $ 325.2k | |
| Founder | no data | no data | no data | |
| Founder | no data | no data | no data | |
| Founder & Member of Corporate Advisory Board | no data | no data | no data | |
| Chief Scientific Officer | 3.5yrs | no data | 0.14% $ 269.5k | |
| Senior Vice President of Clinical Development and Translational Research | no data | no data | no data | |
| Chief Commercial Officer | 1.5yrs | no data | 0.015% $ 28.4k | |
| Chief Medical Officer | less than a year | US$1.64m | no data |
3.1yrs
Average Tenure
59yo
Average Age
Experienced Management: XFOR's management team is considered experienced (3.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 9.8yrs | US$2.04m | 0.46% $ 879.8k | |
| Founder & Member of Corporate Advisory Board | 8.1yrs | no data | no data | |
| Independent Chairman of the Board | 5.8yrs | US$199.34k | 0.017% $ 32.6k | |
| Director | 5.2yrs | US$147.05k | 0.0020% $ 3.8k | |
| Independent Director | 6.7yrs | US$166.05k | 0.0020% $ 3.8k | |
| Independent Director | 3.6yrs | US$154.55k | 0.0020% $ 3.8k | |
| Independent Director | 4.7yrs | US$165.05k | 0.0020% $ 3.8k | |
| Member of Corporate Advisory Board | 8.1yrs | no data | no data | |
| Independent Director | less than a year | US$91.83k | no data | |
| Director | 5.2yrs | US$90.08k | 0.085% $ 164.6k | |
| Independent Director | 2.6yrs | US$152.05k | 0.0020% $ 3.8k |
5.2yrs
Average Tenure
61yo
Average Age
Experienced Board: XFOR's board of directors are considered experienced (5.2 years average tenure).